Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan
Article first published online: 23 JAN 2006
Copyright © 2006 Wiley-Liss, Inc.
International Journal of Cancer
Volume 119, Issue 1, pages 192–195, 1 July 2006
How to Cite
Suruki, R., Hayashi, K., Kusumoto, K., Uto, H., Ido, A., Tsubouchi, H. and Stuver, S. O. (2006), Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan. Int. J. Cancer, 119: 192–195. doi: 10.1002/ijc.21796
- Issue published online: 17 APR 2006
- Article first published online: 23 JAN 2006
- Manuscript Accepted: 28 NOV 2005
- Manuscript Received: 8 AUG 2005
- NIH, USA. Grant Numbers: CA-87982, T32 CA09001-28
- 1http://www.who.int. This is the official web site of the World Health Organization, 2004.
- 7Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus. Int J Cancer 2004; 112: 1075–80., , , , .
- 11Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer 1997; 79: 688–94., , , , , , , , , .
- 15Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy. Liver Int 2005; 25: 85–90., , , , , , , , , .
- 16Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 1999; 29: 1124–30., , , , , , , , , , .
- 17Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of. Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med 1999; 131: 174–81., , , , , , , , , , , , et al.